Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shigella sonnei 53G human challenge study in Kenya
PACTR202306741443913Phase 1Not yet recruiting
- Sponsor
- University of Oxford
- Start
- Oct 2023
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Shigella sonnei strain 53G in shigellosis, sponsored by University of Oxford. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
Shigella sonnei strain 53G
03
Conditions
shigellosis
Beyond the preview
Go deeper on PACTR202306741443913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202306741443913.